Table 1 Literature review of spontaneous remission of histologically confirmed non-small cell lung cancer
Reference | Age/Sex | Cell type | Stage | Smoking | Comorbidities | Treatment |
|---|---|---|---|---|---|---|
Present study | 74/F | NSCLC, P/D | III | None | None | Herbal remedy after ceasing multiple line chemotherapy |
Matsui et al. 2018 [11]* | 56/F | SqCC, M/D | III | Smoker | CTD-ILD and autoimmune hepatitis | None |
Ooi et al. 2018 [16] | 77/M | NSCLC, P/D | III | None | none | None |
Marques et al. 2017 [10] | 75/M | AC, NA | I | Smoker | COPD, heart failure | None |
Park et al. 2016 [17] | 79/M | SqCC, NA | IV | NA | Hypertension, diabetes | None |
Chung et al. 2015 [5] | 67/M | SqCC, NA | IV | NA | None | Chemotherapy and herbal remedy |
Ogawa et al. 2015 [15] | 65/M | NSCLC, P/D | IV | Smoker | none | Radiotherapy |
Menon et al. 2015 [12] | 44/M | NSCLC, P/D | IV | Smoker | HIV | None except HAART on combined HIV infection |
Lopez-Pastorini et al. 2015 [9] | 76/M | LC, P/D | III | Smoker | hypertension | None |
Hwang et al. 2013 [8] | 62/M | NSCLC, P/D | III | Smoker | IPF, diabetes | None |
Mizuno et al. 2011 [13] | 62/M | LC, NA | IV | NA | None | None after surgery for initially stage I lung cancer |
Furukawa et al. 2011 [6] | 56/M | SqCC, NA | I | Smoker | COPD | None |
Gladwish et al. 2010 [7] | 81/F | SqCC, M/D | III | Smoker | Hypothyroidism | Herbal remedy (Essiac tea) |
Nakamura et al. 2009 [14] | 71/M | AC, P/D | III | NA | Anti-NY-ESO-1 immunity disease | None |
Pujol et al. 2007 [18] | 75/F | SqCC, NA | I | Smoker | Anti-Hu antibody syndrome, diabetes | None |
Cafferata et al. 2004 [4] | 68/M | AC, P/D | I | Smoker | COPD, ischemic heart disease | None |
Kappauf et al. 1997 [3] | 61/M | LC, P/D | IV | NA | None | None |
Sperduto et al. 1988 [19] | 61/M | SqCC, NA | IV | Smoker | COPD, basal cell cancer | None |